Ginkgo Bioworks Holdings Cash Flow Statement (2020-2026) | DNA

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-102.41M-1604.99M-592.59M-670.57M-670.13M-173.08M-204.97M-173.31M-302.89M-211.69M-165.91M-217.18M-56.40M-107.53M-7.65M-60.30M-80.75M-80.75M-6.53M10.61M
Share-based Compensation (Quarter)
0.13M1,591.26M652.82M606.51M563.38M108.17M72.99M62.48M53.65M-187.02M40.78M38.23M14.01M-91.78M17.39M22.53M18.10M21.03M15.85M7.59M
Cash from Discontinued Operations (Quarter)
-8.77M-0.25M-2.10M
Gains from Investment Securities (Quarter)
18.48M-77.10M-85.03M-23.51M12.45M-28.87M-1.20M4.48M-1.89M-6.55M-0.94M-3.23M-1.53M
Asset Writedowns and Impairment (Quarter)
9.00M112.40M121.40M47.86M
Change in Working Capital (Quarter)
2.65M2.68M8.52M4.73M
Change in Receivables (Quarter)
86.26M-34.50M0.53M-15.92M-5.77M-28.90M6.77M-5.67M5.00M-1.38M0.67M-0.26M-0.76M1.82M0.24M-3.71M
Change in Inventory (Quarter)
0.76M-0.11M5.33M-0.59M-2.24M-2.66M-1.85M-0.69M
Change in Account Payables (Quarter)
4.55M0.52M26.25M-15.60M-6.76M-14.74M9.68M-6.69M
Change in Accured Expenses (Quarter)
10.46M15.20M9.97M-22.85M1.03M-27.79M19.08M-23.08M-0.82M21.72M10.87M-0.01M-41.96M-9.34M8.87M-13.99M22.12M-6.62M-11.60M3.94M
Other Working Capital Changes (Quarter)
-0.71M9.17M-0.13M-4.25M-0.86M13.75M-7.44M-4.64M-1.47M3.08M-1.15M-0.62M-1.72M-6.60M0.58M1.69M-2.20M5.18M-5.93M6.71M
Cash from Operations (Quarter)
-5.24M-165.54M-19.90M-99.41M-28.36M-104.53M-90.58M-73.53M-73.55M-57.83M-89.26M-84.39M-103.50M-42.44M-42.75M-49.03M-31.61M-47.68M-46.43M-44.27M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
47.90M
Amortization of Deferred Charges (Quarter)
7.21M8.04M8.29M8.31M3.68M5.64M7.43M7.55M7.48M7.38M7.49M7.58M7.63M7.11M6.14M
Depreciation & Amortization (CF) (Quarter)
8.15M8.00M8.94M9.03M8.92M15.67M18.96M17.65M21.06M12.84M12.87M17.33M17.17M15.65M14.82M15.79M14.17M13.66M12.80M12.31M
Investing Activities
Capital Expenditures (Quarter)
5.44M-50.87M-2.21M2.63M9.58M42.27M19.44M13.53M-30.24M38.07M6.71M-5.88M-0.64M62.34M7.62M-7.50M7.54M0.01M-0.09M2.62M
Sales of Property, Plant and Equipment (Quarter)
0.06M-0.06M0.11M-0.11M0.62M2.31M0.07M1.43M0.40M0.06M0.57M
Acquisitions (Quarter)
21.38M-9.34M5.40M
Change in Acquisitions & Divestments (Quarter)
0.06M-0.03M4.52M64.96M-64.96M25.90M108.18M57.99M
Cash from Investing Activities (Quarter)
-30.51M4.23M-35.98M-14.66M-46.49M29.74M-19.41M-11.22M-3.38M-46.67M-12.11M-26.84M-10.20M-13.09M-198.68M-63.89M-72.82M95.10M23.13M11.09M
Financing Activities
Other financing activities (Quarter)
0.00M0.13M0.07M-0.98M-0.09M100.30M0.01M-0.61M-0.00M1.18M0.07M0.01M-0.08M
Cash from Financing Activities (Quarter)
1,547.74M-11.04M-1.19M-0.84M-0.39M97.76M-0.89M-1.38M-0.32M-0.63M-0.84M-0.23M-0.47M-0.20M-0.21M-0.10M9.94M8.14M-0.02M16.49M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
15.09M-15.09M7.59M-24.61M9.15M
Additional items
Exchange Rate Effect (Quarter)
-0.88M-0.01M-0.01M-0.10M-0.09M1.10M-0.03M-0.47M-0.20M0.10M-0.16M-0.02M-0.04M-0.07M0.07M0.19M0.09M-0.15M-0.13M0.04M
Change in Cash (Quarter)
1,511.99M-172.37M-57.08M-115.01M-75.33M24.07M-110.91M-86.61M-77.44M-105.03M-102.37M-111.47M-114.20M-55.80M-250.34M-104.05M-94.39M55.41M-23.70M-16.65M
Free Cash Flow (Quarter)
-10.67M-114.67M-17.69M-102.04M-37.94M-146.80M-110.03M-87.07M-43.31M-95.90M-95.97M-78.51M-102.86M-104.78M-50.37M-41.53M-39.14M-47.68M-46.34M-46.89M
Net Cash Flow (Quarter)
1,512.00M-172.36M-57.08M-114.91M-75.24M22.97M-110.89M-86.14M-77.25M-105.14M-102.21M-111.46M-114.17M-55.72M-241.64M-113.01M-94.48M55.56M-23.32M-16.70M